TY  - JOUR
AU  - Lamanna-Rama, Nicolás
AU  - Casquero-Veiga, Marta
AU  - Ceron, Carlos
AU  - Sobrino, Gorka
AU  - Fernandez-Nueda, Irene
AU  - Kossatz, Susanne
AU  - Sehlin, Dag
AU  - Desco, Manuel
AU  - Salinas, Beatriz
AU  - Cortes-Canteli, Marta
TI  - Alzheimer's Imaging Consortium.
JO  - Alzheimer's and dementia
VL  - 21 Suppl 8
IS  - Suppl 8
SN  - 1552-5260
CY  - Hoboken, NJ
PB  - Wiley
M1  - DKFZ-2025-03047
SP  - e109958
PY  - 2025
N1  - Poster presentation / PMID: 41434183
AB  - Alzheimer's disease (AD) is the most common form of dementia[1]. Despite the advances in the understanding of its main neuropathological hallmarks, a significant gap remains in comprehending this multifactorial neurodegenerative disorder. Contributing factors to AD include chronic vascular dysregulation and a prothrombotic milieu, promoting fibrin accumulation in brain vessels[2]. Fibrin, the main protein component of blood clots, is significantly increased in 60
KW  - Humans
KW  - Alzheimer Disease: diagnostic imaging
KW  - Alzheimer Disease: metabolism
KW  - Alzheimer Disease: pathology
KW  - Animals
KW  - Fibrin: metabolism
KW  - Brain: diagnostic imaging
KW  - Brain: metabolism
KW  - Brain: pathology
KW  - Biomarkers
KW  - Disease Models, Animal
KW  - Fibrin (NLM Chemicals)
KW  - Biomarkers (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:41434183
C2  - pmc:PMC12726136
DO  - DOI:10.1002/alz70862_109958
UR  - https://inrepo02.dkfz.de/record/307448
ER  -